^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Hedera Profiling 2 ctDNA test panel

    Company:
    Hedera
    Type:
    Laboratory Developed Test
    Details
    Evidence

    News

    7ms
    Hedera Dx launches blood based cancer testing that allows larger patient populations to access cancer therapies (Hedera Dx Press Release)
    "Hedera Dx...has unveiled a fully streamlined solution that allows hospitals to adopt liquid biopsy testing locally for their patients with minimal efforts. The solution is a combination of laboratory reagents and a software platform...The solution is called Hedera Profiling 2 ctDNA Test Panel and it integrates easily with the existing instrument infrastructure of a hospital lab. The test is built on actionability, in other words focusing on finding a potential treatment."
    Launch
    |
    Hedera Profiling 2 ctDNA test panel